Symptoms and Complaints Over-all follow-up visits for 2 week period [clinicaltrials_resource:9ef18c01fbeb993dd57437b975c19214]
1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Symptoms and Complaints Over-all follow-up visits for 2 week period [clinicaltrials_resource:9ef18c01fbeb993dd57437b975c19214]
1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.
Bio2RDF identifier
9ef18c01fbeb993dd57437b975c19214
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9ef18c01fbeb993dd57437b975c19214
measure [clinicaltrials_vocabulary:measure]
Symptoms and Complaints
time frame [clinicaltrials_vocabulary:time-frame]
Over-all follow-up visits for 2 week period
description
1-100 Scale for each eye. Zero ...... epresented the most favorable.
identifier
clinicaltrials_resource:9ef18c01fbeb993dd57437b975c19214
title
Symptoms and Complaints Over-all follow-up visits for 2 week period
@en
type
label
Symptoms and Complaints Over-a ...... 18c01fbeb993dd57437b975c19214]
@en